By Josh White
Date: Monday 23 Feb 2026
(Sharecast News) - Novacyt announced on Monday that it has conditionally agreed to acquire Southern Cross Diagnostics for an initial cash consideration of AUD 8.5m (£4.45m), as the molecular diagnostics group looked to expand its footprint in the fast-growing Australian market and accelerate its path to profitability.
By Josh White
Date: Wednesday 22 Oct 2025
(Sharecast News) - Novacyt said on Wednesday that it expects improved second-half performance in 2025, as it outlined a new growth strategy focused on accelerating product development, achieving sustained double-digit revenue growth, and returning to EBITDA profitability.
By Josh White
Date: Friday 12 Sep 2025
(Sharecast News) - Novacyt said on Friday that its Lab 21 Healthcare subsidiary has been fined £52,000 following the conclusion of a Health and Safety Executive prosecution relating to historical operations at its former Axminster site.
| Currency | UK Pounds |
| Share Price | 32.35p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 50.25 |
| 52 Week Low | 32.35 |
| Volume | 20,668 |
| Shares Issued | 70.63m |
| Market Cap | £22.85m |
| Beta | 0.02 |
| RiskGrade | 453 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:10 | 1,000 @ 32.35p |
| 11:06 | 15,030 @ 32.77p |
| 11:05 | 1,132 @ 32.77p |
| 10:13 | 333 @ 32.77p |
| 09:19 | 200 @ 32.77p |
You are here: research